Advanced search
Publication Cover
Expert Review of Ophthalmology Volume 7, 2012 - Issue 2
Submit an article Journal homepage
16
Views
0
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Insight into intraretinal crystalline deposits in type 2 macular telangiectasia

Jaclyn L Kovach Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 311 9th St N, Naples, FL 34102, USA; Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 311 9th St N, Naples, FL 34102, USA. [email protected]
,
Harry W Flynn Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 311 9th St N, Naples, FL 34102, USA; Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 311 9th St N, Naples, FL 34102, USA
&
Ingrid U Scott Departments of Ophthalmology and Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA; Departments of Ophthalmology and Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA
Pages 117-119 | Published online: 09 Jan 2014

References

  • Gass JD, Oyakawa RT. Idiopathic juxtafoveolar retinal telangiectasis. Arch. Ophthalmol.100, 769–780 (1982).
  • Yannuzzi LA, Bardal AMC, Freund KB, Chen KJ, Eandi CM, Blodi B. Idiopathic macular telangiectasia. Arch. Ophthalmol.124, 450–460 (2006).
  • Gamulescu MA, Walter A, Sachs H, Helbig H. Bevacizumab in the treatment of idiopathic macular telangiectasia. Graefes. Arch. Clin. Exp. Ophthalmol.246, 1189–1193 (2008).
  • Kovach JL, Rosenfled PJ. Bevacizumab (Avastin®) therapy for idiopathic macular telangiectasia type II. Retina29, 27–32 (2009).
  • Matsumoto Y, Yuzawa M. Intravitreal bevacizumab therapy for idiopathic macular telangiectasia. Jpn J. Ophthalmol.54, 320–324 (2010).
  • Charbel Issa P, Finger RP, Holz FG, Scholl HP. Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. Br. J. Ophthalmol.92, 941–945 (2008).
  • Charbel Issa P, Finger RP, Kruse K et al. Monthly ranibizumab for nonproliferative macular telangicetasia type 2: a 12-month prospective study. Am. J. Ophthalmol.151, 876–886 (2011).
  • Abujamra S, Bonanomi MT, Cresta FB et al. Idiopathic juxtafoveolar retinal telangiectasis: clinical pattern in 19 cases. Ophthalmologica214, 406–411 (2000).
  • Sallo FB, Leung BA, Chung M et al. MacTel Study Group. Retinal crystals in type 2 idiopathic macular telangiectasia. Ophthalmology118, 2461–2467 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.